PPARγ Expression is Diminished in Macrophages of Recurrent Miscarriage Placentas by Kolben, Theresa Maria et al.
 International Journal of 
Molecular Sciences
Article
PPARγ Expression Is Diminished in Macrophages of
Recurrent Miscarriage Placentas
Theresa Maria Kolben 1, Elisabeth Rogatsch 1, Aurelia Vattai 1, Anna Hester 1, Christina Kuhn 1,
Elisa Schmoeckel 2 ID , Sven Mahner 1, Udo Jeschke 1,* ID and Thomas Kolben 1
1 Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr. 15,
81377 Munich, Germany; Theresa.kolben@med.uni-muenchen.de (T.M.K.);
elisabeth.rogatsch@icloud.com (E.R.); Aurelia.vattai@med.uni-muenchen.de (A.V.);
anna.hester@med.uni-muenchen.de (A.H.); Christina.kuhn@med.uni-muenchen.de (C.K.);
sven.mahner@med.uni-muenchen.de (S.M.); Thomas.kolben@med.uni-muenchen.de (T.K.)
2 Department of Pathology, LMU Munich, Marchioninistr. 27, 81377 Munich, Germany;
elisa.schmoeckel@med.uni-muenchen.de
* Correspondence: udo.jeschke@med.uni-muenchen.de; Tel.: +49-89-4400-74775
Received: 23 May 2018; Accepted: 19 June 2018; Published: 26 June 2018


Abstract: PPARγ belongs to the group of nuclear receptors which is expressed in the trophoblast
and together with other factors is responsible for the maintenance of pregnancy. Apart from that
PPARγ is also a main factor for macrophage polarization. The aim of this study was to investigate
the combined expression pattern and frequency of PPARγ under physiological circumstances and
in spontaneous and recurrent miscarriages in the trophoblast and in maternal macrophages of the
decidua. Human placental tissues of the first trimester (15 physiologic pregnancies, 15 spontaneous
abortion and 16 recurrent miscarriage placentas) were analyzed for expression of the nuclear receptor
PPARγ. Expression changes were evaluated by immunohistochemistry and real time PCR (RT-PCR)
in trophoblast and in maternal macrophages of the decidua. Maternal macrophages were identified
by double immunofluorescence using cluster of differentiation 68 (CD68) as marker for macrophages
and further characterized regarding their M1/M2 polarization status. The intermediate villous
trophoblast revealed a significantly lower PPARγ expression in spontaneous and recurrent abortion.
Maternal macrophages express PPARγ. Their number is significantly enhanced in the decidua of
spontaneous miscarriages whereas in recurrent miscarriages maternal macrophages seem to express
PPARγ only in very few cases. PPARγ is associated with an M2 polarization state that is common for
decidual macrophages. The lack of PPARγ in recurrent miscarriage decidual macrophages seems to
be associated with a specific inflammatory response against the fetus.
Keywords: PPARγ; first trimester placenta; decidual macrophages; miscarriage
1. Introduction
Miscarriage, which is defined as either spontaneous or recurrent, is a common disorder in
pregnancy [1]. It affects 25–50% of all reproductive-aged women. Immunologic, endocrine and
metabolic mechanisms are involved in the success of human pregnancy and disturbances in any
of these processes can lead to fetal loss [2]. Established risk factors are fetal chromosomal or
endocrine disorders for spontaneous miscarriages and the antiphospholipid syndrome, thrombophilia
or maternal anatomical malformations, especially for recurrent pregnancy losses [3]. In nearly 50% of
affected patients, however, the cause of miscarriage remains unknown [4].
Peroxisome proliferator-activated receptor γ (PPARγ) belongs to the family of nuclear receptors [5]
that are key players in maintaining pregnancy [6,7]. PPARγ, together with its heterodimer binding
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partner retinoid X receptor alpha (RXRα), are involved in cell proliferation, cell differentiation, and
organogenesis [8]. RXRα is upregulated in extravillous trophoblast in recurrent miscarriages in
humans [9]. RXRα plays a pivotal role in the receptor family, due to its ability to form heterodimers
with other nuclear receptors. Heterodimer partners include, e.g., peroxisome proliferator-activated
receptor (PPAR), thyroid hormone receptor (TR), and liver X receptor (LXR) [2,10–12]. Especially the
expression of the isoform PPARγ is linked to trophoblast invasion [13] and downregulation of the
isoform RXRα seems to protect from apoptosis in human trophoblasts [9].
Not only trophoblast cells express PPARγ, but also macrophages [14]. Macrophages play a
key role in immune response and they can respond to environmental stimuli by acquiring specific
phenotypes [15]. In response to external cues they will undergo classical M1 activation with high levels
of inflammation and microbicide as well as anti-tumor activity. Alternatively, the M2 pathway contains
mostly parasite containment, tissue remodeling and most importantly in this case immunomodulatory
functions like pregnancy [16–18].
Our former studies showed that the number of decidual macrophages is increased at the
feto-maternal interface of preeclampsia placentas [19] and also in spontaneous miscarriage cases.
An additional finding was the FasL-positivity of these macrophages [20]. Therefore, the aim of this
study was a phenotype characterization of macrophage populations in abortive placental tissue, its
PPARγ expression and the characterization of PPARγ expressing trophoblast sub-types.
2. Results
2.1. Immunohistochemistry
2.1.1. PPARγ-Expression in the Trophoblast
The expression of PPARγ in the nucleus and cytoplasm of trophoblast cells was analyzed in
tissue from healthy pregnancies (15 cases), spontaneous miscarriages (SM, 15 cases), and recurrent
miscarriages (RM, 16 cases; Figure 1a–d). The intermediate villous trophoblast (IVT) revealed a
significantly lower expression in the group with recurrent abortions (Figure 1b) than in the group with
healthy placentas (Figure 1a, IRS 8 vs. 12, p = 0.01). There was a significant downregulation of PPARγ
in the IVT of spontaneous abortions (Figure 1c, IRS 9 vs. 12, p = 0.001) compared to the control group.
Briefly, the staining results are shown in the boxplot in Figure 1d.
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Figure 1. Immunohistochemical staining of Peroxisome proliferator-activated receptor gamma 
(PPARγ) in the villous trophoblast. PPARγ expression is found with high distribution and intensity 
in intermediate villous trophoblastic cells (IVT) of first-trimester placentas. The control group (15 
cases) showed the strongest expression pattern (a). PPARγ was significantly downregulated (p = 
0.01) in trophoblastic tissue of recurrent miscarriage (RM, 16 cases, (b). PPARγ expression in the IVT 
of spontaneous miscarriage tissue (SM, 15 cases), (c) was significantly decreased compared to the 
control (p = 0.001). The boxplot summarizes the statistical data of the immunohistochemical staining 
results (d). Scale is 200 μm. The insert picture is 100 μm scaled. 
2.1.2. CD68 Positive Decidual Macrophages in the Decidua 
CD68 positive macrophages were investigated in the placenta of healthy pregnancies (15 cases), 
SM (15 cases), and RM (16 cases; Figure 2a–d). The number of CD68 positive macrophages was low 
in the decidua basalis of control specimens (Figure 2a). The macrophages were slightly increased in 
decidua basalis RM samples, but without statistical significance (p = 0.181) (Figure 2b; median 
number of macrophages = 21 vs. 16). Decidual macrophages were significantly increased in the 
decidua basalis SM group (p = 0.013) (Figure 2c; median number of macrophages 32 vs. 16). A 
summary of the staining results is shown in Figure 2d. 
Figure 1. Immunohistochemical staining of Peroxisome proliferator-activated receptor gamma (PPARγ)
in the villous trophoblast. PPARγ expression is found with high distribution and intensity in
intermediate villous trophoblastic cells (IVT) of first-trimester placentas. The control group (15 cases)
showed the strongest expression pattern (a). PPARγ was significantly downregulated (p = 0.01) in
trophoblastic tissue of recurrent miscarriage (RM, 16 cases, (b). PPARγ expression in the IVT of
spontaneous miscarriage tissue (SM, 15 cases), (c) was significantly decreased compared to the control
(p = 0.001). The boxplot summarizes the statistical data of the immunohistochemical staining results
(d). Scale is 200 µm. The insert picture is 100 µm scaled.
2.1.2. CD68 Positive Decidual Macrophages in the Decidua
CD68 positive macrophages were investigated in the placenta of healthy pregnancies (15 cases),
SM (15 cases), and RM (16 cases; Figure 2a–d). The number of CD68 positive macrophages was low
in the decidua basalis of control specimens (Figure 2a). The macrophages were slightly increased in
decidua basalis RM samples, but without statistical significance (p = 0.181) (Figure 2b; median number
of macrophages = 21 vs. 16). Decidual macrophages were significantly increased in the decidua basalis
SM group (p = 0.013) (Figure 2c; median number of macrophages 32 vs. 16). A summary of the staining
results is shown in Figure 2d.
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Figure 2. Immunohistochemical staining of decidual macrophages with CD68 as a marker for 
macrophage positivity. Decidual macrophages were increased in RM (16 cases) and SM samples (15 
cases) compared to the control group (15 cases), (a). In recurrent miscarriage specimens, the decidual 
macrophages tended to be upregulated (p = 0.181) (b). In spontaneous miscarriage samples, the 
population of macrophages was significantly higher compared to the control (p = 0.013) (c). Summary 
of staining results of CD68 positive decidual macrophages (d). Scale is 200 μm. The insert picture is 
100 μm scaled. 
2.2. Double Immunofluorescence 
Identification of PPARγ-Expressing Cells in the Decidua Basalis 
Decidua basalis tissue of regular first trimester pregnancies (15 cases), SM (15 cases) and RM (16 
cases) was double stained using antibodies against PPARγ (green staining), and CD68 (red staining). 
Nuclear staining appeared in blue. PPARγ + CD68 double immunofluorescence staining was 
performed to investigate the macrophage expression of PPARγ in RM, SM and control groups. CD68 
staining in the cytoplasm of normal decidual cells is shown in Figure 3a. Figure 3b presents the 
cytoplasmic staining of PPARγ positive cells from the same area. The depiction of CD68 and PPARγ 
is represented as a co-expression by triple filter excitation in Figure 3c. Both markers are 
ubiquitously expressed in the healthy placenta (Figure 3a–c). A large number of CD68-positive 
macrophages was observed in RM samples (Figure 3d), although with almost no PPARγ expression 
(Figure 3e). Triple filter excitation demonstrates (Figure 3f) a near absence of PPARγ in macrophages 
of recurrent miscarriages. A large population of CD68 positive macrophages (Figure 3g) and PPARγ 
expressing cells (Figure 3h) was detected in SM samples. Figure 3i shows a strong co-expression of 
both markers. We identified CD68 positive macrophages also expressing PPARγ in the healthy and 
in the spontaneous miscarriage placenta. In the group of recurrent miscarriages only very few 
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Figure 2. Immunohistochemical staining of decidual macrophages with CD68 as a marker for
macrophage positivity. Decidual macrophages were increased in RM (16 cases) and SM samples
(15 cases) compared to the control group (15 cases), (a). In recurrent miscarriage specimens,
the decidual macrophages tended to be upregulated (p = 0.181) (b). In spontaneous miscarriage
samples, the population of macrophages was significantly higher compared to the control (p = 0.013) (c).
Summary of staining results of CD68 positive decidual acrophages (d). Scale is 200 µm. The insert
picture is 100 µm scaled.
2.2. Double Immunofluorescence
Identification of PPARγ-Expressing Cells in the Decidua Basalis
Decidua basalis tissue of regular first trimester pregnancies (15 cases), SM (15 cases) and RM
(16 cases) was double stained using antibodies against PPARγ (green staining), and CD68 (red
staining). Nuclear staining appeared in blue. PPARγ + CD68 double immunofluorescence staining
was performed to investigate the macrophage expression of PPARγ in RM, SM and control groups.
CD68 staining in the cytoplas of normal decidual cells is shown in Figure 3a. Figure 3b presents
the cytoplasmic staining of PPARγ positive cells from the same area. The depiction of CD68 and
PPARγ is represented as a co-expression by triple filter excitation in Figure 3c. Both markers are
ubiquitously expressed in the healthy placenta (Figure 3a–c). A large number of CD68-positive
macrophages was observed in RM samples (Figure 3d), although with almost no PPARγ expression
(Figure 3e). Triple filter excitation demonstrates (Figure 3f) a near absence of PPARγ in macrophages
of recurrent miscarriages. A large population of CD68 positive macrophages (Figure 3g) and PPARγ
expressing cells (Figure 3h) was detected in SM samples. Figure 3i shows a strong co-expression
of both markers. We identified CD68 positive macrophages also expressing PPARγ in the healthy
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and in the spontaneous miscarriage placenta. In the group of recurrent miscarriages only very few
PPARγ-expressing macrophages (5–8% of the macrophages in RM are PPARγ-positive) were detected.
Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  5 of 15 
 
PPARγ-expressing macrophages (5–8% of the macrophages in RM are PPARγ-positive) were 
detected. 
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positive macrophages was found in RM (16 cases), (d). PPARγ-positive cells are shown in (e). Triple 
filter excitation showed an absence of PPARγ positive macrophages (f). Both markers (CD68, (g) and 
PPARγ, (h)) are co-expressed in the group of SM (15 cases), (i). All pictures are 40× lens. 
2.3. Characterization of the Macrophage Population in Recurrent Miscarriage Cases 
Because macrophages in RM cases (16 cases) expressed PPARγ only in 5–8% of the total 
macrophage population compared to healthy control tissue (15 cases) and SM (15 cases), we further 
characterized these cells with a panel of M1/M2 markers and CD68. The M1 marker iNOS is 
expressed in 2–5% of the macrophages in healthy controls (CD 68 Figure 4a; iNOS Figure 4b, triple 
filter excitation Figure 4c). In RM cases, iNOS is expressed in 90% of the macrophages (CD68 Figure 
4d, iNOS Figure 4e, triple filter excitation Figure 4f). TLR2 is intensely expressed in the healthy 
decidua but showed no co-expression with macrophages (CD 68 Figure 5a, TLR2 Figure 5b, triple 
filter excitation Figure 5c). In RM cases, TLR2 as M1 marker is co-expressed with macrophages in 80–
90% of the cases (CD68 Figure 5d, TLR2 Figure 5e, triple filter excitation Figure 5f). The chemokine 
CCL1 is a marker for M2b polarized macrophages. In healthy controls, 40–50% of the macrophages 
showed co-expression with CCL1 (CD68 Figure 6a, CCL1 Figure 6b, triple filter excitation Figure 6c). 
In RM cases, only 5–10% of the macrophages showed co-expression with CCL1 (CD68 Figure 6d, 
CCL1 Figure 6e, triple filter excitation Figure 6f). CX3C chemokine receptor 1 (CX3CR1) as a M2 
macrophage marker is widely expressed (>95%) on healthy control decidual macrophages (CD68 
Figure 7a, CX3CR1 Figure 7b, triple filter excitation Figure 7c). In RM cases, only 40–50% of the 
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Figure 3. Double Immunofluorescence of CD68 & PPARγ. CD68 (red staining), PPARγ (green staining),
nuclear staining (blue). CD68 (a) and PPARγ (b) are expressed in the decidua of healthy placenta
(15 cases), co-expression presented as triple filter yellow (c). High distribution of CD68 positive
macrophages was found in RM (16 cases), (d). PPARγ-positive cells are shown in (e). Triple filter
xcitation showed an bsenc of PPARγ positive macrophages (f). Both markers (CD68, (g) and PPARγ,
(h)) are co-expressed in the group of SM (15 cases), (i). All pictures are 40× lens.
2.3. Characterization of the Macrophage Populatio in Recurrent Miscarriage Cases
Because macrophages in RM cases (16 cases) expressed PPARγ only in 5–8% of the total
macrophage opulation compared to healthy control tissue (15 cases) and SM (15 cases), we further
characterized these cells it a panel of M1/M2 markers and CD68. The M1 marker iNOS is expressed
in 2–5% of the macrophages in healthy controls (CD 68 Figure 4a; iNOS Figure 4b, triple filter excitation
Figure 4c). I RM cases, iNOS is expressed in 90% of the macrophages (CD68 Figure 4d, iNOS i re 4e,
triple filter excitation Figure 4f). TLR2 is intensely expressed i the healthy deci ua but s owed no
co-expression ith macrophages (CD 68 Figure 5a, TLR2 Figure 5b, triple filter excitation Figure 5c).
In RM cases, TLR2 as M1 marker is co-expressed with macrophages in 80–90% of the cases (CD68
Figure 5d, TLR2 Figure 5e, triple filter excitation Figure 5f). The chemokine CCL1 is a marker for M2b
polarized macrophages. In healthy controls, 40–50% of the macrophages showed co-expression with
CCL1 (CD68 Figure 6a, CCL1 Figure 6b, triple filter excitation Figure 6c). In RM cases, only 5–10%
of the macrophages showed co-expression with CCL1 (CD68 Figure 6d, CCL1 Figure 6e, triple filter
excitation Figure 6f). CX3C chemokine receptor 1 (CX3CR1) as a M2 macrophage marker is widely
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expressed (>95%) on healthy control decidual macrophages (CD68 Figure 7a, CX3CR1 Figure 7b, triple
filter excitation Figure 7c). In RM cases, only 40–50% of the macrophages showed co-expression with
C X3CR1 (CD68 Figure 7d, CX3CR1 Figure 7e, triple filter excitation Figure 7f).
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Figure 4. Double Immunofluorescence of CD68 and iNOS. CD68 (green staining), iNOS (red 
staining), nuclear staining (blue). CD68 (a) and iNOS (b) are co-expressed only in few macrophages 
in the decidua of healthy placenta, presented as triple filter yellow (c). High distribution of CD68 
positive macrophages was found in RM (d). iNOS positive cells are shown in (e). Triple filter 
excitation shows a co-expression of iNOS and macrophages (f). All pictures are 40× lens. 
   
   
Figure 5. Double Immunofluorescence of CD68 and TLR2. CD68 (green staining), TLR2 showed 
strong expression in the healthy decidua (red staining), nuclear staining (blue). CD68 (a) and TLR2 
(b) are not co-expressed in the decidua of healthy placenta, presented as triple filter yellow (c). CD68 
positive macrophages in RM placenta (d). TLR2 positive cells are shown in (e). Triple filter excitation 
shows a co-expression of TLR2 and macrophages (f) in the RM placenta. All pictures are 40× lens. 
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Figure 4. Double Immunofluorescence of CD68 and iNOS. CD68 (green staining), iNOS (red staining),
nuclear staining (blue). CD68 (a) and iNOS (b) are co-expressed only in few macrophages in the
decidua of healthy placenta, presented as triple filter yellow (c). High distribution of CD68 positive
macrophages was found in RM (d). iNOS positive cells are shown in (e). Triple filter excitation shows a
co-expression of iNOS and macrophages (f). All pictures are 40× lens.
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positive macrophages in RM placenta (d). TLR2 positive cells are shown in (e). Triple filter excitation 
shows a co-expression of TLR2 and macrophages (f) in the RM placenta. All pictures are 40× lens. 
d e f 
d e 
a b c 
a b c 
f 
Figure 5. Double Immunofluorescence of CD68 and TLR2. CD68 (green staining), TLR2 showed strong
expression in the healthy decidua (red staining), nuclear staining (blue). CD68 (a) and TLR2 (b) are
not co-expressed in the decidua of healthy placenta, presented as triple filter yellow (c). CD68 positive
macrophages in RM placenta (d). TLR2 positive cells are shown in (e). Triple filter excitation shows a
co-expression of TLR2 and macrophages (f) in the RM placenta. All pictures are 40× lens.
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Figure 6. Double Immunofluorescence of CD68 and CCL1. CD68 (green staining), CCL1 showed 
intense expression in the healthy decidua (red staining), nuclear staining (blue). CD68 (a) and CCL1 
(b) are co-expressed in the decidua of healthy placenta in a number of cells, presented as triple filter 
yellow (c). CD68 positive macrophages in RM placenta (d). Only few CCL1 positive cells are shown 
in (e). Triple filter excitation shows a diminished co-expression of CCL1 and macrophages (f) in the 
RM placenta. All pictures are 40× lens. 
   
    
Figure 7. Double Immunofluorescence of CD68 and CX3CR1. CD68 (green staining), CX3CR1 
showed expression in a variety of different cell types including endometrial glands and decidual 
stromal cells [21] in the healthy decidua (red staining), nuclear staining (blue). CD68 (a) and CX3CR1 
(b) are co-expressed in the decidua of healthy placenta in almost all CD 68-positive cells (>95%), 
presented as triple filter yellow (c). CD68 positive macrophages in RM placenta (d). Only 40–50% 
CX3CR1 expressing cells (e) showed co-expression with CD68, as shown in (f). All pictures are 40× 
lens. 
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Figure 6. Double Immunofluorescence of CD68 and CCL1. CD68 (green staining), CCL1 showed
intense expression in the healthy decidua (red staining), nuclear staining (blue). CD68 (a) and CCL1
(b) are co-expressed in the decidua of healthy placenta in a number of cells, presented as triple filter
yellow (c). CD68 positive macrophages in RM placenta (d). Only few CCL1 positive cells are shown in
(e). Triple filter excitation shows a diminished co-expression of CCL1 and macrophages (f) in the RM
placenta. All pictures are 40× lens.
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Figure 7. Double Immunofluorescence of CD68 and CX3CR1. CD68 (green staining), CX3CR1 showed
expression in a variety of different cell types including endometrial glands and decidual stromal
cells [21] in the healthy decidua (red staining), nuclear staining (blue). CD68 (a) and CX3CR1 (b) are
co-expressed in the decidua of healthy placenta in almost all CD 68-positive cells (>95%), presented
as triple filter yellow (c). CD68 positive macrophages in RM placenta (d). Only 40–50% CX3CR1
expressing cells (e) showed co-expression with CD68, as shown in (f). All pictures are 40× lens.
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2.4. Evaluation of PPARγ Expression with Real-Time RT-PCR (TaqMan)
PPARγ mRNA (PPARG) expression was analyzed in placental tissue from SM, RM and healthy
controls by quantitative RT-PCR. PPARγ was significantly downregulated in SM (15 cases, 1.8-fold;
p = 0.010) and in RM (16 cases, 1.5-fold; p = 0.004) compared to the control group (15 cases, Figure 8).
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although they were PPARγ positive. In former studies, we could show that these macrophages 
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Figure 8. Results of PPARγ mRNA expression analysis with TaqMan RT-PCR from trophoblastic tissue.
PPARγ mRNA expression was significantly downregulated in the miscarriage groups (SM, 15 cases,
p = 0.01) and RM, 16 cases, p = 0.004)) compared to the healthy controls (15 cases). This bar graph shows
the mean of relative PPARγ expression; therefore, the presentation of error bars is not appropriate.
3. Discussion
Within this study we could show that PPARγ is downregulated in the intermediate
villous trophoblast (IVT) in both spontaneous (SM) and recurrent miscarriage (RM) placentas.
The downregulation of PPARγ was confirmed by RT-PCR in both miscarriage pregnancy cases.
In addition, we showed that in recurrent miscarriages, decidua basalis macrophages are nearly
PPARγ-negative, whereas in normal controls and surprisingly also in SM decidua basalis macrophages
are all PPARγ-positive. The additional characterization of the macrophage polarization status using
the M1 polarization markers TLR2 and iNOS [22] and the M2 polarization markers CCL1 and CX3CR1
confirmed the loss of M2 polarized marcrophages [23] in recurrent miscarriages.
PPARγ as nuclear receptor is already known to be essential for the maturation of alternatively
activated M2 macrophages [24]. M2 macrophages and decidual macrophages have mainly immune
regulatory and homeostatic properties [25]. These macrophages have little in common with
pro-inflammatory M1 macrophages, which is in line with the role for decidual macrophages in
establishing and sustaining fetal tolerance [26].
In addition, rosiglitazone as a selective peroxisome PPARγ agonist has been shown to induce
an M2 macrophage polarization via activating the PPARγ pathway [27,28]. The activation of PPARγ
suppresses gene transcription by interfering with signal transduction pathways, such as the nuclear
factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB), Signal transducer and activator of
transcription (STAT), and Activator protein 1 (AP-1) pathways that are involved in pro-inflammatory
immune responses [29–31]. It is a striking result of this study, that we could identify the loss of PPARγ
in decidual macrophages of patients with recurrent miscarriages but not in patients with SM and of
course in normal control placentas.
In spontaneous miscarriages, we identified a significant increase of decidual macrophages,
although they were PPARγ positive. In former studies, we could show that these macrophages
express FasL [20]. The expression of FasL on decidual macrophages had been already described
before [32].
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The role of the Fas/FasL system in the conditions of spontaneous abortion and pregnancy had
been described for T cell apoptosis by decidual and trophoblast cells earlier [33,34]. Our group
was able to describe an increased expression of FasL in decidual macrophages of spontaneous
miscarriages [20]. Therefore, we speculated that FasL expression by macrophages could be a part of an
M2-like polarization. FasL-expressing macrophages could induce apoptosis to Fas-bearing activated
T-cells reducing potentially harmful immune responses against the semi-allogenic embryo. We further
assumed that macrophages might mediate the T-cell triggered trophoblast apoptosis highlighting an
alternative way of inducing apoptosis in SM [15].
Placental growth is exponential in the first trimester of pregnancy and involves coordinated
events in trophoblast and mesenchyme, one of these is the differentiation of progenitor cytotrophoblast
cells into intermediate villous trophoblast cells (IVT). These IVT are programmed to either fuse with
the syncytium, or are transferred to extravillous trophoblast cells [35]. We found a downregulation of
PPARγ in the IVT compartment in both spontaneous and recurrent miscarriage on protein as well as on
mRNA-level. Already decades ago, the natural binding partner of PPARγ, the RXRα was described in
this trophoblast compartment: RAR and RXR, both types of receptors were present in the proliferative
intermediate villous trophoblast [36]. Later, RXRα was found to play a crucial role in pregnancy and
is a key regulator of apoptosis in trophoblasts of patients with recurrent miscarriages [9]. PPARγ,
on the other hand, was also described to be dysregulated in different trophoblast compartments
of the miscarriage placenta [37,38], although PPARγ expression in the IVT was never investigated
before. Interestingly, Fournier et al. described that activation of PPARγ induces accumulation of
lipids, villous trophoblast differentiation and inhibits trophoblast invasiveness [39]. In addition,
the expression of PPARγ is downregulated by stimulation of trophoblast cells with either arachidonic
acid or 15d-PGJ2 [40]. Because we identified a downregulation of PPARγ in the IVT of miscarriages
and a missing PPARγ expression in macrophages of RM cases, we might speculate that PPARγ ligands
(e.g., prostaglandins) are released to a higher extent under these pathological circumstances.
4. Materials and Methods
4.1. Patient Data
The Institutional Review Board of the Ludwig-Maximilian-University, Munich, (Number of
approval: 337-06, 29 December 2006) approved this study. All women signed an informed consent
allowing analysis of all clinical and laboratory data mentioned in this study. Placental tissue from
spontaneous miscarriages (SM) (n = 15) and recurrent miscarriages (RM) (n = 16) at gestational weeks
4 to 13 was obtained at the Department of Obstetrics and Gynecology, LMU Munich. Placental
tissue from legal terminations of healthy pregnancies (n = 15) served as control group. The tissue
was collected at a private practice clinic in Munich, Germany. The control group specimens were
confirmed as healthy by a blinded independent pathologist. All placental material was acquired
by dilatation and curettage, without any prior pharmaceutical induction. In cases of SM and RM,
the operation was performed within 24 h after diagnosis. Instantly, after the uterine curettage,
the obtained tissue was either frozen or formalin fixed for further analysis. All patients included
had an inconspicuous family and medical history, which was obtained systematically. Patients with
common disorders, autoimmune diseases, thrombophilia and microbiological infections (Bacteria and
Chlamydia trachomatis) were excluded. Chromosomal abnormalities were ruled out by karyotype
analysis in all samples, as described recently [11,41]. Table 1 summarizes the number of samples used
for immunohistochemical staining for each gestational week. Table 2 shows the demographic and
clinical characteristics of the study population.
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Table 1. Number of slides used for immunohistochemical staining for each gestational week.
Gestational Age Normal Pregnancy Spontaneous Miscarriage Recurrent Miscarriage
4th week 0 0 1
7th week 2 1 3
8th week 4 5 5
9th week 2 2 4
10th week 3 3 0
11th week 0 3 2
12th week 3 1 1
13th week 1 0 0
n = 15 n = 15 n = 16
Table 2. Demographic and clinical characteristics of the study population.
Characteristics * Normal Pregnancyn = 15
Spontaneous Miscarriage
n= 15
Recurrent Miscarriage
n= 16
p Value
(Kruskal Wallis Test)
Maternal age
(years)
31.18 ± 8.06
(18.7−43.3)
37.8 ± 4.51
(29.2–43.2)
35.76 ± 4.8
(29.5–46.9) 0.049
Gestational age
(weeks)
9.53 ± 1.95
(7–13)
8.4 ± 1.89
(7–12)
9.3 ± 1.49
(4–12) 0.276
Gravidity 4 ± 1.8(1–7)
1.6 ± 0.9
(1–4)
3.1 ± 1.1
(2–5) 0.001
Parity 2 ± 1.1(0–4)
0.9 ± 0.8
(0–2)
0.3 ± 0.6
(0–2) 0.003
Values are Mean ± S.D. * Mean, standard deviation, range.
4.2. Immunohistochemistry
Formalin-fixed tissue slides were embedded in paraffin wax for immunohistochemistry. Samples
were deparaffinized in xylol for 20 min and rinsed in 100% ethanol. Methanol/H2O2 incubation for
20 min was performed to inhibit endogenous peroxidase reaction. Afterwards, the specimens were
rehydrated in deescalating alcohol gradients, starting with 100% ethanol and ending with distilled
water. The samples were cooked in a pressure pot, containing a sodium citrate buffer (pH = 6.0), which
consisted of 0.1 mM citric acid and 0.1 mM sodium citrate in distilled water. Subsequently, samples
were washed in PBS twice and incubated with a blocking solution (reagent 1, ZytoChem Plus HRP
Polymer System (Mouse/Rabbit), Zytomed, Berlin, Germany) for 5 min. Incubation with the primary
antibody was performed with each section for 16 h at 4 ◦C. All antibodies used are listed in Table 3.
Following every subsequent step, samples were washed twice in PBS (pH = 7.4). Blocking solutions,
containing post block (reagent 2) for 20 min and HRP-Polymer (reagent 3) for 30 min, were applied.
The chromogen-substrate staining was carried out using the Liquid DAB+ Substrate Chromogen
System (Dako Scientific, Glostrup, Denmark), 1 min for CD68 and 2 min for PPARγ. The reaction
was stopped by applying distilled water. Finally, tissue samples were counterstained with Hemalaun
for 2 min and blued in tap water. Specimens were dehydrated in an ascending alcohol gradient and
cover slipped with Eukitt® quick hardening mounting medium (Sigma Aldrich, St. Louis, MO, USA).
Positive control (human colon tissue) as well as negative control staining was carried out as described
previously [10,40]. All slides were analyzed using the microscope Leitz Wetzlar (Wetzlar, Germany;
Type 307-148.001 514686). The immunoreactive score (IRS) was used for evaluation of the intensity and
distribution pattern of antigen expression. This semi-quantitative score is calculated as follows: the
optical staining intensity (grades: 0 = none, 1 = weak, 2 = moderate, 3 = strong staining) is multiplied
by the total percentage of positively stained cells (0 = none, 1 ≤ 10%, 2 = 11–50%, 3 = 51–80% and
4 ≥ 81% of the cells). This multiplication has a minimum of 0 and a maximum of 12. Analysis of all
slides was performed independently by two experienced staff members. Total number of macrophages
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in a magnification field of 40× lens was calculated three times each in 3 different areas of the decidua
basalis. The median number was calculated.
Table 3. Antibodies used for immunohistochemical characterization and double immunofluorescence
of placental tissue samples.
Antibody Isotype Clone Dilution Source
PPARγ a,b rabbit IgG polyclonal
1:500 in PBS a
1:500 in Dako b
Abcam Serotec, Cambridge, UK
DAKO (S322); Carpenteira, CA, USA
CD 68 a,b mouse IgG1 monoclonal
1:8000 in PBS a
1:8000 in Dako b
Sigma Aldrich (CL1346), St. Louis, MO, USA
DAKO (S322); Carpenteira, CA, USA
iNOS b Rabbit IgG polyclonal 1:3000 in Dako
Thermo Scientific, (NPA3-030A)
DAKO (S322); Carpenteira, CA, USA
TLR2 b Rabbit IgG polyclonal 1:750 in Dako
Sigma Aldrich, St. Louis, MO, USA
Dako (S322); Carpenteira, CA, USA
CCL1 b Rabbit IgG polyclonal 1: 50 in Dako
Sigma Aldrich, St. Louis, , MO, USA
Dako (S322); Carpenteira, CA, USA
CX3CR1 b Rabbit IgG polyclonal 1: 400 in Dako
Abcam Serotec, Cambridge, UK
Dako (S322); Carpenteira, CA, USA
Cy-2 or -3 b
goat IgG
anti-mouse polyclonal 1:500
b Dianova, Hamburg, Germany
Cy-2 or -3 b
goat IgG
anti-rabbit polyclonal 1:100
b Dianova, Hamburg, Germany
a antibodies used for immunohistochemistry, b antibodies used for immunofluorescence.
4.3. Immunofluorescence
4.3.1. Evaluation of PPARγ-Expressing Cells as Macrophages
For the visualization of PPARγ-expressing cells in the trophoblast, tissue samples of SM, RM,
both first-trimester abortion placentas, and healthy controls (first trimester) were used. The antibodies
used are shown in Table 3. Double immunofluorescence staining for PPARγ and CD68 as a specific
macrophage marker was performed to identify expression patterns in the nucleus and the cytoplasm.
4.3.2. Evaluation of M1/M2 Marker on Decidual Macrophages
In order to further characterize the macrophage polarization state, TLR2 and iNOS, as well as
CCL1 and CX3CR1, were used for M1 and M2 polarization, respectively. Each specimen was incubated
overnight at 4 ◦C with monoclonal anti-CD68 mouse IgG1 and one of the polyclonal IgG antibodies
against PPARγ, TLR2, iNOS, CCL1, or CX3CR1. Polyclonal Cy-2- and polyclonal Cy-3-conjugated
antibodies (Dianova, Hamburg, Germany) were used as secondary antibodies. Incubation was
performed for 30 min at room temperature. Samples were fixed with Vectashield® mounting medium
with DAPI (Vector Laboratories; Burlingame, CA, USA) and analyzed with the Axioskop fluorescent
photomicroscope (Zeiss; Oberkochen, Germany). Images were taken with the Axiocam camera system
(Zeiss CF20DXC).
4.4. Evaluation of PPARγ with Real-Time RT-PCR (Taq Man)
4.4.1. RNA Extraction from Placental Tissue
mRNA extraction was accomplished using the placental tissue of 15 women with SM, 16 women
with RM and 15 healthy controls from the 7th to the 12th week of gestation. RNA extraction using
10 mg tissue of each sample was accomplished with RNeasy® Lipid Tissue Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s protocol.
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4.4.2. Reverse Transcription
According to the protocol reverse transcription (RT) was carried out with the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems™, Fisher Scientific Company, Waltham, MA,
USA) and placed in a mastercycler® gradient (Eppendorf, Hamburg, Germany). RT conditions were as
follows: 10 min at 25 ◦C, 2 h at 37 ◦C, 5 min at 85 ◦C and continued by a hold step at −20 ◦C.
4.4.3. Real-Time Reverse Transcription PCR
After conversion of RNA to cDNA, PCR was performed on all samples individually. Real-Time
Reverse Transcription PCRs were covered with optical caps in optical 96-well (Applied Biosystems™,
Fisher Scientific Company, Waltham, MA, USA) reaction microtiter plates. Each reaction was
accomplished with a volume of 20 µL, including 1 µL cDNA, 8 µL H2O (DEPC treated DI water;
Sigma, Taufkirchen, Germany) and 10 µL TaqMan® Fast Universal PCR Master Mix 2× (Applied
Biosystems, Nr. 4367846; 50 mL). The total contained 1 µL TaqMan® Gene Expression Assay 20×
(HS01115513_m1 for PPARγ, Applied Biosystems). The temperature protocol was as follows: 20 s at
95 ◦C, 40 cycles of amplification, denaturation for 3 s at 95 ◦C and denaturation plus annealing process
for 30 s at 60 ◦C. Processing the PCR assays was performed using the 7500 Fast Real-Time PCR System
(Applied Biosystems), and quantification was accomplished by the 2−∆∆Ct method using β-actin as
housekeeping gene (Applied Biosystems, Hs_99999903_m1).
4.5. Statistics
Analysis of the collection and statistical data was processed with the SPSS software version 24
(SPSS, Chicago, IL, USA) and Excel version 12.3.1 (Microsoft Windows 2016; Redmond, WA, USA).
The Mann-Whitney U signed-rank test was used for the comparison of two independent groups.
p-values < 0.05 were considered to be statistically significant.
5. Conclusions
Mouse knockout models showed that PPARγ is essential for placentation. PPARγ depletion
leads to fetal loss in early pregnancy due to the missing PPARγ expression and extended placental
defects [42]. In addition, decidual M1-like macrophage polarization events are associated with PPARγ
modulation strategies [14]. Therefore, the PPARγ pathway is a new molecular target for future
preventive strategies for the treatment of spontaneous and recurrent miscarriages.
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